bioRxiv Science⌕ Search

bioRxiv · 10.1101/2023.09.20.558617

Non-invasive assessment of stimulation-specific changes in cerebral glucose metabolism with functional PET

Abstract

Functional positron emission tomography (fPET) with [18F]FDG allows one to quantify stimulation-induced dynamics in glucose metabolism independent of neurovascular coupling. However, the gold standard for quantification requires arterial blood sampling, which can cause discomfort for the participant and increases complexity of the experimental protocol. These constraints have limited the widespread applicability of fPET, especially in the clinical routine. Therefore, we introduce a novel approach, which enables the assessment of the dynamics in cerebral glucose metabolism without the need for an input function. MethodsWe tested the validity of a mathematical derivation on the basis of two independent data sets (DS). For DS1, 52 healthy volunteers (23.2 {+/-} 3.3 years, 24 females) completed a visuo-spatial motor coordination task (the video game Tetris(R)) and for DS2, 18 healthy participants (24.2 {+/-} 4.3 years, 8 females) performed an eyes-open/finger tapping task, both during a [18F]FDG fPET scan. Task-specific changes in metabolism were assessed with the general linear model (GLM) and cerebral metabolic rate of glucose (CMRGlu) was quantified with the Patlak plot as the reference standard. Simplified outcome parameters, such as GLM beta values of task effects and percent signal change (%SC) of both parameters were estimated. These were compared for task-relevant brain regions and on a whole-brain level. ResultsIn general, we observed higher agreement with the reference standard for DS1 (radiotracer administration as bolus + constant infusion) compared to DS2 (constant infusion only). Across both data sets, strong correlations were found between regional task-specific beta estimates and CMRGlu (r = 0.763...0.912). Additionally, %SC of beta values exhibited excellent agreement with %SC of CMRGlu (r = 0.909...0.999). Average activation maps showed a high spatial similarity between CMRGlu and beta estimates (Dice = 0.870...0.979) as well as %SC (Dice = 0.932...0.997), respectively. ConclusionTask-specific changes in glucose metabolism can be reliably estimated using %SC of GLM beta values, eliminating the need for any blood sampling. This approach streamlines fPET imaging, albeit with the trade-off of being unable to quantify baseline metabolism. The proposed simplification enhances the applicability of fPET, allowing for widespread employment in research settings and clinical investigations. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=101 SRC="FIGDIR/small/558617v1_ufig1.gif" ALT="Figure 1"> View larger version (25K): org.highwire.dtl.DTLVardef@77faeaorg.highwire.dtl.DTLVardef@fa3495org.highwire.dtl.DTLVardef@926353org.highwire.dtl.DTLVardef@b70da0_HPS_FORMAT_FIGEXP M_FIG C_FIG

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Godbersen, G. M., Falb, P., Klug, S., Silberbauer, L., Reed, M. B., Nics, L., Hacker, M., Lanzenberger, R., Hahn, A.. 2023-09-22. Non-invasive assessment of stimulation-specific changes in cerebral glucose metabolism with functional PET. https://doi.org/10.1101/2023.09.20.558617

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Rab10 and Arhgef7 interact to promote axon extension by linking vesicle supply and exocytosis

The formation of functional neural circuits begins with the extension of a single axon by immature neurons. Axon elongation requires an expansion of the plasma membrane that depends on the polarization of vesicle trafficking and exocytosis. It is not completely understood how the increased transport of vesicles into the growing axon is linked to their subsequent insertion into the plasma membrane. An analysis of early stages of neuronal differentiation indicates that an asymmetry in neurite length precedes axon specification and the accumulation of PPVs in the nascent axon. We show that increasing the transport of vesicles in unpolarized neurons is sufficient to promote the extension of additional axons. This effect indicates that an increased supply of vesicles stimulates their subsequent insertion into the membrane to allow neurite growth. The link between vesicle transport and exocytosis is mediated by the interaction of Rab10 with Arhgef7. Rab10 stimulates Arhgef7 activity on PPVs as a GEF for Cdc42b to promote axon extension through exocyst-dependent exocytosis, suggesting that their interaction links the increased supply of PPVs to their exocytosis.

neuroscience↗

Subcellular Spatial Profiling Unveils Links Between Neuritic Plaques with Selective Tau Vulnerability in Alzheimer's Disease

Alzheimer's disease (AD) features widespread extracellular amyloid-{beta} plaques but selective intraneuronal tau accumulation in cortical layers II/III and V, while layer IV remains relatively resistant. Here, we combined subcellular spatial transcriptomics with co-registered A{beta} and pTau immunohistochemistry to determine why neurons exposed to comparable plaque-associated pathology differ in somatic pTau accumulation. Plaque-associated neuritic stress occurred similarly across layers, but layer IV neurons showed attenuated pTau accumulation and reduced somatic expression of a shared neurite-soma stress program involving DCTN1, CALM3, NORAD, and PIN1. Trajectory analysis within layers identified tau-vulnerable and resistant neuronal states implicating calcium signaling, retrograde transport, and lysosomal function. Notably, astrocytic APOE-neuronal LRP1 co-expression increased significantly along the pTau-vulnerable trajectory, and APOE {epsilon}4 was associated with stronger coupling of local plaque pathology to pTau-associated molecular programs. These findings reveal neuronal programs and neuron-glia interactions underlying selective tau vulnerability and resistance in AD, highlighting potential tau-targeting therapeutics.

neuroscience↗

Widespread oscillatory suppression in autism persists in the absence of psychotropic medication.

Purpose: Investigate the neural oscillatory activity associated with autism spectrum disorder (ASD) using electroencephalographic (EEG) recordings in children and adolescents. Compare the corresponding oscillatory power between ASD patients taking psychotropic medication with a drug-naive group. Methods: ASD diagnosis was done using DSM-IV and CARS (Childhood Autism Rating Scale). EEG recordings employed 22 scalp electrodes (10/20 system). ASD vs. neurotypical groups were matched for sex and age (5 females; average age: ~10 years old). We analyzed the resting state (eyes open) EEG power spectrum during ~2-minute recordings. The multitaper FFT method was used to estimate spectral power for the delta, theta, alpha, beta and gamma frequency bands. We pooled together data from several electrodes to compute comprehensive power spectra and assess the oscillatory behavior of macro brain regions. Results: We observed widespread (~4Hz - 20Hz) oscillatory suppression comprising the theta, alpha and beta frequency bands. The most widespread and robust ASD-associated power suppression was in the high theta and alpha bands. Delta and gamma bands showed no significant power change for any of the brain regions studied. Results from a subgroup of patients (N = 9) who never used psychotropics confirmed these findings, indicating that they are not an artifact of medication. Conclusion: Suppression in theta, alpha and beta oscillations may offer insights into the neurophysiological underpinnings of autism and could be used as an accessible and comprehensive tool in ASD diagnosis, regardless of the patients being or not on medication.

neuroscience↗